Finance

Beta
Lists
2289:HKG
Charmacy Pharmaceutical Co Ltd
HK$5.70
+4.20%
(+0.23) 1D
Jun 12, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2289...
Open
HK$5.50
High
HK$5.70
Low
HK$5.50
Mkt. cap
615.60M
Avg. vol.
517.00
Volume
3.50K
Dividend
6.03%
Quarterly dividend
HK$0.09
Ex-dividend date
May 27, 2026
P/E ratio
11.49
52-wk high
HK$7.40
52-wk low
HK$4.30
EPS
HK$0.50
Shares outstanding
108.00M
No. of employees
847
Open
HK$5.50
High
HK$5.70
Low
HK$5.50
Mkt. cap
615.60M
Avg. vol.
517.00
Volume
3.50K
Dividend
6.03%
Quarterly dividend
HK$0.09
Ex-dividend date
May 27, 2026
P/E ratio
11.49
52-wk high
HK$7.40
52-wk low
HK$4.30
EPS
HK$0.50
Shares outstanding
108.00M
No. of employees
847
News stories
From sources across the web
About Charmacy Pharmaceutical Co Ltd
CEO-
Employees847
FoundedFeb 18, 1984
Headquarters-
SectorHealth care provider
Websitechmyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.08B
1.08B
1.11B
1.11B
Cost of goods sold
999.20M
999.20M
1.03B
1.03B
Cost of revenue
999.20M
999.20M
1.03B
1.03B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.46M
41.46M
49.23M
49.23M
Operating expense
43.97M
43.97M
58.26M
58.26M
Total operating expenses
1.04B
1.04B
1.08B
1.08B
Operating income
34.36M
34.36M
31.41M
31.41M
Other non operating income
-2.84M
-2.84M
-1.55M
-1.55M
EBT including unusual items
16.31M
16.31M
15.84M
15.84M
EBT excluding unusual items
16.57M
16.57M
17.54M
17.54M
Income tax expense
5.44M
5.44M
3.57M
3.57M
Effective tax rate
33.37%
33.37%
22.56%
22.56%
Other operating expenses
2.36M
2.36M
2.41M
2.41M
Net income
10.87M
10.87M
12.27M
12.27M
Net profit margin
1.01%
1.01%
1.10%
1.10%
Earnings per share
-
-
-
-
Interest and investment income
573.53K
573.53K
524.55K
524.55K
Interest expense
-15.53M
-15.53M
-12.89M
-12.89M
Net interest expenses
-14.95M
-14.95M
-12.36M
-12.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
39.48M
39.48M
36.59M
36.59M
Gain or loss from assets sale
-3.89K
-3.89K
93.14K
93.14K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer